Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2

Frontiers in Microbiology(2022)10.3389/fmicb.2022.959577Source: DataRank Database

RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2 is a research paper published in Frontiers in Microbiology (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

geo gen uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.12)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Ivan Akhrymuk,Amy Smith ORCID,Paul T. Winnard,Shih‐Chao Lin ORCID,Lauren Panny ORCID

Live enrichment

PubMed:36090095 PMC:PMC9453862 OpenAlex:https://openalex.org/W4293101522

FAMRI

Grant: R01CA207208

National Institutes of Health

Grant: 1R01CA207208-01

Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression

FWCI

2.12

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://doi.org/10.3389/fmicb.2022.959577

publisherhttps://doi.org/10.3389/fmicb.2022.959577

publisherhttps://www.frontiersin.org/articles/10.3389/fmicb.2022.959577/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36090095

repositoryhttps://doaj.org/article/8955e83bf9ba4aa1a0372b40e904b979

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchViral gastroenteritis research and epidemiology0301 basic medicine03 medical and health sciences

Keywords

HelicaseBiologyVirusVirologyRNA Helicase AGeneRNAViral replicationLineage (genetic)GeneticsHost (biology)Computational biologyRNA helicaseTmprss2Viral IsolatesRk-33Host-targeted AntiviralDdx3 InhibitorSars-cov-2MicrobiologyQR1-502

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2

FAIR Checklist

Authors (9)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)